首页> 美国卫生研究院文献>World Journal of Gastroenterology >Preparation of human hepatocellular carcinoma-targeted liposome microbubbles and their immunological properties
【2h】

Preparation of human hepatocellular carcinoma-targeted liposome microbubbles and their immunological properties

机译:人肝癌靶向脂质体微泡的制备及其免疫学性质

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

AIM: To prepare the human hepatocellular carcinoma-(HCC)-targeted liposome microbubbles and to investigate their immunological properties.METHODS: Human hepatocarcinoma specific monoclonal antibody HAb18 was attached to the surface of home-made liposome microbubbles by static attraction to prepare the targeted liposome microbubbles. The combination of HAb18 with liposome microbubbles was confirmed by the slide agglutination test and immunofluorescent assay. Their immunological activity was measured by ELISA. Rosette formation test, rosette formation blocking test and immun-ofluorescent assay were used to identify the specific binding of targeted liposome microbubbles to SMMC-7721 hepatoma cells, and cytotoxicity assay was used to detect their effect on human hepatocytes.RESULTS: The targeted liposome microbubbles were positive in the slide agglutination test and immunofluorescent assay. ELISA indicated that the immunological activity of HAb18 on the liposome microbubbles was similar to that of free HAb18. SMMC-7721 cells were surrounded by the targeting liposome microbubbles to form rosettes, while the control SGC-7901 gastric cancer cells were not. Proliferation of SMMC-7721 cells and normal human hepatocytes was not influenced by the targeted liposome microbubbles.CONCLUSION: The targeted liposome microbubbles with a high specific biological activity have been successfully prepared, which specifically bind to human hepatocarcinoma cells, and are non-cytotoxic to hepatocytes. These results indicate that the liposome microbubbles can be used as a HCC-targeted ultrasound contrast agent that may enhance ultrasound images and thus improve the diagnosis of HCC, especially at the early stage.
机译:目的:制备靶向人肝癌的脂质体微泡并研究其免疫学特性。方法:将人肝癌特异性单克隆抗体HAb18通过静态吸引附着于自制脂质体微泡的表面,制备靶向脂质体。微气泡。通过载玻片凝集试验和免疫荧光测定证实了HAb18与脂质体微泡的结合。通过ELISA测量它们的免疫活性。采用玫瑰花结形成试验,玫瑰花结形成阻断试验和免疫荧光法鉴定靶向脂质体微泡与SMMC-7721肝癌细胞的特异性结合,并通过细胞毒性试验检测其对人肝细胞的影响。在玻片凝集试验和免疫荧光测定中均为阳性。 ELISA表明,HAb18对脂质体微泡的免疫活性与游离HAb18相似。 SMMC-7721细胞被靶向脂质体微泡包围形成玫瑰花结,而对照SGC-7901胃癌细胞则没有。结论:成功制备了具有高比生物学活性的靶向脂质体微泡,其与人肝癌细胞具有特异性结合,且对人肝癌细胞无细胞毒性。SMMC-7721细胞和正常人肝细胞的增殖不受靶向脂质体微泡的影响。肝细胞。这些结果表明,脂质体微泡可以用作靶向HCC的超声造影剂,可以增强超声图像,从而改善HCC的诊断,尤其是在早期阶段。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号